| 1 | Consensus statement on the pathology of IgG4-related disease | Modern Pathology | 2012 | 2,389 |
| 2 | Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases | Modern Pathology | 2000 | 971 |
| 3 | Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma | Modern Pathology | 2005 | 963 |
| 4 | Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases | Modern Pathology | 2011 | 944 |
| 5 | A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal | Modern Pathology | 2018 | 937 |
| 6 | Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 | Modern Pathology | 2017 | 891 |
| 7 | Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies | Modern Pathology | 2020 | 810 |
| 8 | Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics | Modern Pathology | 2013 | 686 |
| 9 | Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Modern Pathology | 2010 | 598 |
| 10 | ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor | Modern Pathology | 2001 | 580 |
| 11 | Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology | 2002 | 580 |
| 12 | Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT) | Modern Pathology | 2000 | 560 |
| 13 | HER2 testing in gastric cancer: a practical approach | Modern Pathology | 2012 | 536 |
| 14 | Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model | Modern Pathology | 2012 | 501 |
| 15 | Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues | Modern Pathology | 2005 | 484 |
| 16 | The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine | Modern Pathology | 2012 | 481 |
| 17 | Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of Outcome | Modern Pathology | 2000 | 474 |
| 18 | Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis | Modern Pathology | 2011 | 468 |
| 19 | The histopathology of fatal untreated human respiratory syncytial virus infection | Modern Pathology | 2006 | 460 |
| 20 | NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls | Modern Pathology | 2019 | 459 |
| 21 | Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach | Modern Pathology | 2000 | 458 |
| 22 | Digital pathology and artificial intelligence in translational medicine and clinical practice | Modern Pathology | 2021 | 440 |
| 23 | EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset | Modern Pathology | 2009 | 433 |
| 24 | Gleason grading and prognostic factors in carcinoma of the prostate | Modern Pathology | 2004 | 425 |
| 25 | COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City | Modern Pathology | 2020 | 424 |
| 26 | Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative | Modern Pathology | 2015 | 423 |
| 27 | Molecular characterization of cancers with NTRK gene fusions | Modern Pathology | 2018 | 422 |
| 28 | A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression | Modern Pathology | 2020 | 418 |
| 29 | Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients | Modern Pathology | 2010 | 403 |
| 30 | Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis | Modern Pathology | 2008 | 400 |
| 31 | Basal cell carcinoma: biology, morphology and clinical implications | Modern Pathology | 2006 | 392 |
| 32 | Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases | Modern Pathology | 2002 | 383 |
| 33 | Comprehensive analysis of HE4 expression in normal and malignant human tissues | Modern Pathology | 2006 | 378 |
| 34 | Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray | Modern Pathology | 2003 | 376 |
| 35 | Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine | Modern Pathology | 2017 | 373 |
| 36 | Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation | Modern Pathology | 2009 | 370 |
| 37 | p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Modern Pathology | 2011 | 370 |
| 38 | Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model | Modern Pathology | 2017 | 364 |
| 39 | Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications | Modern Pathology | 2009 | 359 |
| 40 | The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 | Modern Pathology | 2000 | 358 |
| 41 | Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms | Modern Pathology | 2011 | 356 |
| 42 | Thyroid carcinoma: molecular pathways and therapeutic targets | Modern Pathology | 2008 | 355 |
| 43 | Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors | Modern Pathology | 2000 | 352 |
| 44 | Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns | Modern Pathology | 2010 | 352 |
| 45 | Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas | Modern Pathology | 2016 | 350 |
| 46 | Origins and molecular pathology of ovarian cancer | Modern Pathology | 2005 | 346 |
| 47 | Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features | Modern Pathology | 2003 | 345 |
| 48 | Pulmonary pathology of severe acute respiratory syndrome in Toronto | Modern Pathology | 2004 | 345 |
| 49 | β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation | Modern Pathology | 2010 | 344 |
| 50 | Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles | Modern Pathology | 2004 | 342 |
